| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $68.0M | -4.4% | -5.3% |
| Cost of Revenue | $25.4M | -4.5% | -0.4% |
| Gross Profit | $42.6M | -4.3% | -8.0% |
| R&D Expense | $9.6M | +5.5% | +9.1% |
| SG&A Expense | $15.6M | +0.0% | +3.3% |
| Operating Income | -$8.4M | -54.2% | -516.8% |
| Pre-tax Income | -$8.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $136.5M | +50.9% | +73.0% |
| Accounts Receivable | $362.6M | -5.4% | -3.8% |
| Current Assets | $520.4M | +1.5% | -1.8% |
| Total Assets | $676.2M | +0.1% | -1.9% |
| Current Liabilities | $388.4M | -0.1% | -1.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $62.9M | — | — |
| Capital Expenditures | $7.5M | — | — |
| Investing Cash Flow | $17.4M | — | — |
| Financing Cash Flow | -$44.9M | — | — |
| Free Cash Flow | $55.4M | — | — |
| -34.4% |
| -2402.5% |
| Income Tax | -$1.7M | -97.9% | -391.1% |
| Net Income | -$6.5M | -23.9% | -607.5% |
| EPS (Basic) | -$0.14 | -27.3% | -600.0% |
| EPS (Diluted) | -$0.14 | -27.3% | -600.0% |
| $431.1M |
| -0.2% |
| +1.2% |
| Stockholders' Equity | $245.1M | +0.7% | -6.9% |